3,5-Difluoromethcathinone (also known as 3,5-DFMC) is a chemical compound from the cathinone family that has been sold as a designer drug, first being identified in Australia in 2009.[1]
Clinical data | |
---|---|
Other names | 3-DFMC, 3,5-Difluoromethcathinone |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H11F2NO |
Molar mass | 199.201 g·mol−1 |
3D model (JSmol) | |
| |
|
Legal status
editIn the United Kingdom, 3,5-DFMC is a controlled drug under the cathinone blanket ban.[citation needed]
3,5-DFMC is an Anlage II controlled drug in Germany.[citation needed]
See also
editReferences
edit- ^ Davis S, Rands-Trevor K, Boyd S, Edirisinghe M (April 2012). "The characterisation of two halogenated cathinone analogues: 3,5-difluoromethcathinone and 3,5-dichloromethcathinone". Forensic Science International. 217 (1–3): 139–45. doi:10.1016/j.forsciint.2011.10.042. PMID 22088945.